Yposkesi
develops gene therapies for the treatment of AAV and lentiviral vector... Read moreYposkesi
develops gene therapies for the treatment of AAV and lentiviral vector... Read more
News
Jun 23, 2023
Korea Biomedical Review
Yposkesi: SK pharmteco secures Europe's largest CGT production capacity
Apr 28, 2023
Contract Pharma
Yposkesi: Yposkesi Launches LentiSure Lentiviral Vector Production Platform
Apr 05, 2023
Contract Pharma
Yposkesi: Yposkesi Launches LentiSure Lentiviral Vector Production Platform
Nov 28, 2022
BioPharma-Reporter
Yposkesi: Yposkesi is on a roll: CDMO's expanded facility to be operational in early 2024
Nov 02, 2022
The Korea Herald
Yposkesi: [Exclusive] SK Pharmteco's French CDMO to complete construction of new plant in Q1 2023
Aug 24, 2021
Manufacturing Chemist
Yposkesi: Yposkesi joins BioPhorum CGT consortium
Jun 17, 2021
BioPharma-Reporter
Yposkesi: Yposkesi begins construction of second cell and gene facility
Jun 15, 2021
Manufacturing Chemist
Yposkesi: Yposkesi begins construction of second bioproduction site
Jun 15, 2021
FiercePharma
Yposkesi: With $71M investment, French CDMO Yposkesi set to double capacity and become a viral vector force
Jun 14, 2021
The Korea Herald
Yposkesi: SK Inc.'s French bio arm sets to facility expansion
Yposkesi Competitors
1
2
3
4
5
6
7
8
9
10